文献速递新生儿儿童感染

孕产妇与新生儿脐血SARS-CoV-2抗体及胎盘转移率评估

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.
PubMed 文献 · JAMA Pediatr · 2021-01-01

该队列研究在宾夕法尼亚医院纳入2020年4月9日至8月8日分娩的1714名孕妇,其中1471对母婴有配对血清。6%孕妇分娩时检出SARS-CoV-2 IgG和/或IgM抗体,83名血清阳性母亲所生新生儿中87%脐血检出IgG,脐血IgG与母亲IgG浓度正相关(r=0.886;P<.001),转移率随感染至分娩时间延长而增加。

要点

  • 孕妇SARS-CoV-2 IgG可经胎盘转移至新生儿,无症状与有症状感染均可发生。
  • 脐血IgG浓度与母亲IgG浓度正相关(r=0.886;P<.001)。
  • 胎盘转移率随母亲感染至分娩时间延长而增加。

核心结论

  • 孕妇SARS-CoV-2 IgG抗体在无症状及有症状感染后均可经胎盘转移至新生儿。
  • 脐血抗体浓度与母亲抗体浓度及感染至分娩时间相关。
  • 母源性SARS-CoV-2特异性抗体可能为新生儿提供COVID-19保护。

研究设计与样本

  • 队列研究,地点为宾夕法尼亚州费城宾夕法尼亚医院。
  • 2020年4月9日至8月8日在该院分娩的1714名孕妇,其中1471对母婴有配对血清用于抗体检测。

主要发现

  • 1471名孕妇中83名(6%;95%CI,5%-7%)分娩时检出SARS-CoV-2 IgG和/或IgM抗体。
  • 83名血清阳性母亲所生新生儿中72名(87%;95%CI,78%-93%)脐血检出IgG。
  • 所有脐血标本均未检出IgM,血清阴性母亲所生婴儿均未检出抗体。
  • 11名血清阳性母亲所生婴儿血清阴性:5名(45%)母亲仅IgM抗体阳性,6名(55%)母亲IgG浓度显著低于血清阳性婴儿的母亲。
  • 脐血IgG浓度与母亲IgG浓度正相关(r=0.886;P<.001)。

关键数值与推荐

  • 无症状、轻、中、重度COVID-19孕妇均观察到胎盘转移率大于1.0。
  • 胎盘转移率随母亲感染至分娩时间延长而增加。

临床怎么用

  • 对于孕期SARS-CoV-2感染母亲,可检测脐血IgG评估母源性抗体转移情况。
  • 母源性抗体可能为新生儿提供COVID-19保护,支持孕期疫苗接种策略的思考。

局限性

  • 研究为单中心队列,结果外推需谨慎。
  • 仅检测受体结合域IgG和IgM,未评估其他抗体功能。
  • 未报告新生儿临床结局与抗体保护力的直接关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Maternally derived antibodies are a key element of neonatal immunity. Understanding the dynamics of maternal antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and subsequent transplacental antibody transfer can inform neonatal management as well as maternal vaccination strategies. OBJECTIVE: To assess the association between maternal and neonatal SARS-CoV-2-specific antibody concentrations. DESIGN, SETTING, AND PARTICIPANTS: This cohort study took place at Pennsylvania Hospital in Philadelphia, Pennsylvania. A total of 1714 women delivered at the study site between April 9 and August 8, 2020. Maternal and cord blood sera were available for antibody measurement for 1471 mother/newborn dyads. EXPOSURES: SARS-CoV-2. MAIN OUTCOMES AND MEASURES: IgG and IgM antibodies to the receptor-binding domain of the SARS-CoV-2 spike protein were measured by enzyme-linked immunosorbent assay. Antibody concentrations and transplacental transfer ratios were analyzed in combination with demographic and clinical data. RESULTS: The study cohort consisted of 1714 parturient women, with median (interquartile range) age of 32 (28-35) years, of whom 450 (26.3%) identified as Black/non-Hispanic, 879 (51.3%) as White/non-Hispanic, 203 (11.8%) as Hispanic, 126 (7.3%) as Asian, and 56 (3.3%) as other race/ethnicity. Among 1471 mother/newborn dyads for which matched sera were available, SARS-CoV-2 IgG and/or IgM antibodies were detected in 83 of 1471 women (6%; 95% CI, 5%-7%) at the time of delivery, and IgG was detected in cord blood from 72 of 83 newborns (87%; 95% CI, 78%-93%). IgM was not detected in any cord blood specimen, and antibodies were not detected in any infant born to a seronegative mother. Eleven infants born to seropositive mothers were seronegative: 5 of 11 (45%) were born to mothers with IgM antibody only, and 6 of 11 (55%) were born to mothers with significantly lower IgG concentrations compared with those found among mothers of seropositive infants. Cord blood IgG concentrations were positively correlated with maternal IgG concentrations (r = 0.886; P < .001). Placental transfer ratios more than 1.0 were observed among women with asymptomatic SARS-CoV-2 infections as well as those with mild, moderate, and severe coronavirus disease 2019. Transfer ratios increased with increasing time between onset of maternal infection and delivery. CONCLUSIONS AND RELEVANCE: In this cohort study, maternal IgG antibodies to SARS-CoV-2 were transferred across the placenta after asymptomatic as well as symptomatic infection during pregnancy. Cord blood antibody concentrations correlated with maternal antibody concentrations and with duration between onset of infection and delivery. Our findings demonstrate the potential for maternally derived SARS-CoV-2 specific antibodies to provide neonatal protection from coronavirus disease 2019.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 2021. PMID: 33512440. doi:10.1001/jamapediatrics.2021.0038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。